GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (NYSE:SOLV) » Definitions » Cash Flow from Others

SOLV (Solventum) Cash Flow from Others : $34 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Cash Flow from Others?

Solventum's cash flow from others for the three months ended in Dec. 2024 was $4 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2024 was $34 Mil.


Solventum Cash Flow from Others Historical Data

The historical data trend for Solventum's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Cash Flow from Others Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Others
74.00 74.00 64.00 -15.00 34.00

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 9.00 10.00 11.00 4.00

Solventum Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $34 Mil.

Solventum Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Solventum's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Solventum Business Description

Traded in Other Exchanges
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.